Photoacoustic tomography is a non-invasive imaging technique based on the detection of broadband acoustic emissions
generated by the absorption of light in tissue. This technique utilises the high contrast of optical imaging with high
resolution from ultrasound imaging. However, the ability to detect these emissions above the noise level ultimately limits
the depth to which imaging can be performed. Introduction of light-absorbing gold nanoparticles can improve the
signal-to-noise ratio in tissue, through greater optical absorption and targeting specific cell populations, thereby
enhancing contrast and the ability to delineate tissue types. For sufficiently high laser fluence incident on a nanoparticle,
a transient vapour cavity is formed and undergoes inertial collapse, generating a broadband emission and possibly
additional contrast. However, the laser fluence required to achieve this typically exceeds the maximum permissible
exposure (MPE) for tissue. Through the combination of ultrasonic and optical pulses, the light and sound thresholds
required to repeatedly generate inertial cavitation were reduced to 11.1 mJ/cm2 and 1.5 MPa respectively. Experiments
employed a transparent acrylamide gel possessing a small (<600 μm) spherical region doped with 80 nm diameter gold
nanoparticles and simultaneously exposed to pulsed laser light (532 nm) and pulsed ultrasound (1.1 MHz). The
amplitude of broadband emissions induced by both light and sound exceeded that produced by light alone by almost two
orders of magnitude, thereby facilitating imaging a deeper depth within tissue. 2D images of doped regions generated
from conventional photoacoustic and ultrasound-enhanced emissions are presented and compared.
High intensity focused ultrasound (HIFU) is a powerful noninvasive tool for targeted tissue ablation. Monitoring of the
treatment process and efficacy in real time, however, remains challenging. The tissue necrosis during the HIFU exposure
leads to changes in optical absorption and scattering coefficients. In this paper, we explore the use of acousto-optic
imaging (AOI), a hybrid technique that combines ultrasound with diffuse light to obtain deep-tissue optical contrast at
ultrasound resolution, to sense the changes in optical contrast at depth in tissue associated with the onset formation and
development of the necrosed tissue region. In this technique, the tissue to be treated is illuminated with near-infrared
light and a continuous, amplitude-modulated focused ultrasound beam is used to induce thermal tissue necrosis as well
as the acousto-optic (AO) interaction. The AOI signal is detected via a photorefractive crystal (PRC)-based
interferometer, and then fed into a lock-in amplifier tuned to the ultrasound modulation frequency. As a thermal lesion
forms in the ultrasound focal zone, which is also the zone of AO interaction, the AOI signal diminishes in amplitude
owing to enhanced optical attenuation. It is further shown that the reduction of the AOI signal is correlated with the
volume of ensuing lesion. Therefore, the evolution of AOI signal as a function of time provides a means for continuous
monitoring of HIFU treatment process as well as exposure guidance.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.